TRAVOPROST (ISOMER FREE)

TRAVOPROST (ISOMER FREE) was reported 3223 times

TRAVOPROST (ISOMER FREE) is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 IRIS CONVEX 2 0.6667
1 VERTEBRAL END PLATE INFLAMMATION 13 0.6500
2 MALIGNANT MEDIASTINAL NEOPLASM 42 0.3818
3 SCLERAL BUCKLING SURGERY 2 0.3333
4 ADRENAL CYST 12 0.1091
5 TEAR BREAK UP TIME DECREASED 2 0.0909
6 HEMISENSORY NEGLECT 3 0.0857
7 GLAUCOMA DRAINAGE DEVICE PLACEMENT 3 0.0517
8 CONJUNCTIVAL PIGMENTATION 2 0.0500
9 NEUROPATHIC PRURITUS 2 0.0488
10 CONJUNCTIVAL CYST 3 0.0469
11 TRABECULECTOMY 4 0.0435
12 STAG HORN CALCULUS 4 0.0421
13 EYELASH INJURY 2 0.0400
14 JOINT DEFORMITY 3 0.0400
15 CONJUNCTIVAL SCAR 6 0.0397
16 PUNCTURE SITE BRUISE 2 0.0392
17 CORNEAL IRRITATION 3 0.0375
18 SINUS PERFORATION 2 0.0270
19 BURSITIS INFECTIVE 12 0.0221
20 EYE OPACITY 2 0.0217
21 PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED 2 0.0213
22 ERYTHROPSIA 2 0.0204
23 CILIARY BODY DISORDER 2 0.0202
24 AXONAL AND DEMYELINATING POLYNEUROPATHY 2 0.0196
25 CORNEAL EXFOLIATION 2 0.0196
26 BLOOD IMMUNOGLOBULIN E INCREASED 44 0.0182
27 OCULAR SURFACE DISEASE 5 0.0178
28 XANTHELASMA 2 0.0174
29 HYPOTONY OF EYE 7 0.0167
30 CHOROIDAL EFFUSION 12 0.0149
31 REACTION TO PRESERVATIVES 12 0.0147
32 CHOROIDAL DETACHMENT 8 0.0144
33 SWEATING FEVER 2 0.0144
34 ELECTROLYTE DEPLETION 7 0.0142
35 CORNEA VERTICILLATA 4 0.0132
36 ANTERIOR CHAMBER DISORDER 3 0.0130
37 OPEN ANGLE GLAUCOMA 8 0.0130
38 HAEMORRHAGIC CYST 5 0.0129
39 TRICHIASIS 4 0.0126
40 MACULAR DETACHMENT 3 0.0124
41 EYELID INJURY 2 0.0114
42 EYELASH CHANGES 2 0.0113
43 TRACHEO-OESOPHAGEAL FISTULA 7 0.0110
44 ARTERIAL INSUFFICIENCY 2 0.0108
45 TREATMENT FAILURE 895 0.0108
46 LID SULCUS DEEPENED 4 0.0107
47 CHEST TUBE INSERTION 2 0.0106
48 TONGUE HAEMORRHAGE 12 0.0102
49 PRODUCT DESIGN ISSUE 7 0.0098
50 RETICULOCYTOSIS 2 0.0094
51 CORNEAL INFECTION 2 0.0092
52 MYOTONIA 2 0.0090
53 FLUID REPLACEMENT 3 0.0089
54 RETINAL ARTERY THROMBOSIS 2 0.0088
55 PUNCTATE KERATITIS 8 0.0087
56 INADEQUATE ASEPTIC TECHNIQUE IN USE OF PRODUCT 3 0.0083
57 INTRAOCULAR PRESSURE DECREASED 4 0.0076
58 KYPHOSCOLIOSIS 2 0.0076
59 INSTILLATION SITE ERYTHEMA 4 0.0076
60 GROWTH OF EYELASHES 6 0.0076
61 EROSIVE DUODENITIS 6 0.0075
62 LENTIGO MALIGNA 2 0.0075
63 GINGIVAL DISCOLOURATION 4 0.0074
64 CYST RUPTURE 5 0.0074
65 SUBACUTE CUTANEOUS LUPUS ERYTHEMATOSUS 13 0.0073
66 ILIAC ARTERY OCCLUSION 2 0.0073
67 GASTROENTERITIS SALMONELLA 6 0.0072
68 CHEMICAL BURNS OF EYE 2 0.0072
69 GASTROINTESTINAL BACTERIAL INFECTION 8 0.0070
70 RETINAL PIGMENT EPITHELIOPATHY 3 0.0069
71 LENS DISORDER 2 0.0069
72 XEROPHTHALMIA 4 0.0068
73 JOINT NOISE 13 0.0066
74 INTRAOCULAR PRESSURE INCREASED 84 0.0066
75 NEOPLASM PROSTATE 2 0.0064
76 ANAPHYLACTOID SHOCK 3 0.0064
77 BRONCHIECTASIS 43 0.0064
78 METAPLASIA 3 0.0064
79 LACRIMATION DECREASED 3 0.0063
80 KERATIC PRECIPITATES 3 0.0063
81 NEUTROPENIC INFECTION 6 0.0063
82 PRODUCT CONTAINER ISSUE 51 0.0059
83 MACULAR FIBROSIS 4 0.0059
84 EYE ALLERGY 9 0.0058
85 INTRAOCULAR PRESSURE TEST ABNORMAL 4 0.0057
86 DETACHMENT OF RETINAL PIGMENT EPITHELIUM 5 0.0056
87 GASTROINTESTINAL VASCULAR MALFORMATION HAEMORRHAGIC 2 0.0053
88 KERATOCONUS 2 0.0053
89 CORNEAL TRANSPLANT 4 0.0051
90 PRODUCT DELIVERY MECHANISM ISSUE 27 0.0050
91 N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED 7 0.0050
92 PROCTITIS ULCERATIVE 3 0.0050
93 OBSTRUCTIVE UROPATHY 2 0.0050
94 BLOOD POTASSIUM ABNORMAL 13 0.0049
95 MYOPATHY TOXIC 3 0.0049
96 NECROSIS ISCHAEMIC 2 0.0043
97 ADRENAL NEOPLASM 2 0.0043
98 OPTIC NEUROPATHY 9 0.0042
99 OESOPHAGEAL ADENOCARCINOMA 2 0.0042
100 EAR INJURY 2 0.0040
101 FULL BLOOD COUNT ABNORMAL 42 0.0040
102 EYELID PAIN 8 0.0039
103 HYPHAEMA 2 0.0038
104 AORTIC DISORDER 3 0.0038
105 BLEPHARITIS 15 0.0037
106 BONE FRAGMENTATION 2 0.0036
107 PERIORBITAL PAIN 3 0.0035
108 OPTIC NERVE INJURY 4 0.0034
109 CORNEAL EPITHELIUM DEFECT 2 0.0034
110 INSTILLATION SITE IRRITATION 4 0.0034
111 EYELID IRRITATION 8 0.0032
112 FOREIGN BODY IN EYE 3 0.0031
113 CANCER PAIN 8 0.0031
114 CORNEAL OEDEMA 7 0.0031
115 CHALAZION 2 0.0031
116 EYELID MARGIN CRUSTING 9 0.0031
117 DACRYOSTENOSIS ACQUIRED 4 0.0031
118 RETINAL DISORDER 8 0.0031
119 ABSCESS NECK 2 0.0030
120 ULCERATIVE KERATITIS 8 0.0029
121 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 3 0.0028
122 PLATELET DISORDER 7 0.0028
123 NORMOCYTIC ANAEMIA 4 0.0027
124 CORNEAL DEPOSITS 2 0.0027
125 FOREIGN BODY SENSATION IN EYES 17 0.0027
126 CYSTOID MACULAR OEDEMA 5 0.0027
127 SENSITISATION 2 0.0026
128 EYELID EXFOLIATION 2 0.0025
129 CONJUNCTIVAL HYPERAEMIA 9 0.0025
130 EXCESSIVE GRANULATION TISSUE 2 0.0025
131 NEUTROPHIL COUNT ABNORMAL 7 0.0025
132 VERTEBRAL FORAMINAL STENOSIS 2 0.0024
133 SCIATIC NERVE INJURY 2 0.0024
134 SEROUS RETINAL DETACHMENT 2 0.0024
135 GINGIVAL ERYTHEMA 2 0.0023
136 ENDOCRINE OPHTHALMOPATHY 2 0.0023
137 IRITIS 7 0.0023
138 TENSION 14 0.0023
139 EYE IRRITATION 131 0.0023
140 POLYP 14 0.0021
141 OCULAR DISCOMFORT 24 0.0021
142 GLAUCOMA 41 0.0021
143 ATYPICAL FEMUR FRACTURE 6 0.0021
144 PRODUCT AFTER TASTE 2 0.0021
145 DARK CIRCLES UNDER EYES 3 0.0020
146 RECTAL POLYP 2 0.0020
147 CONJUNCTIVITIS ALLERGIC 3 0.0020
148 PERSECUTORY DELUSION 5 0.0020
149 BLOOD CULTURE POSITIVE 6 0.0020
150 ERYSIPELAS 10 0.0020
151 KERATITIS 6 0.0020
152 BLOOD PRESSURE DIASTOLIC ABNORMAL 5 0.0020
153 CONJUNCTIVAL OEDEMA 2 0.0019
154 ABSCESS JAW 2 0.0019
155 KERATOPATHY 3 0.0019
156 OCULAR HYPERAEMIA 90 0.0019
157 VASCULAR CALCIFICATION 2 0.0019
158 INSTILLATION SITE REACTION 2 0.0018
159 EYELID DISORDER 4 0.0017
160 EYE DISCHARGE 18 0.0017
161 SPONDYLOLISTHESIS 3 0.0017
162 EYE PAIN 97 0.0017
163 PRODUCT CONTAMINATION MICROBIAL 2 0.0017
164 EYE INJURY 5 0.0016
165 CHEST X-RAY ABNORMAL 5 0.0016
166 METAMORPHOPSIA 3 0.0016
167 INTERVERTEBRAL DISC DEGENERATION 15 0.0016
168 BLOOD PRESSURE SYSTOLIC ABNORMAL 4 0.0016
169 XEROSIS 2 0.0016
170 BLOOD UREA DECREASED 2 0.0016
171 URINE OUTPUT DECREASED 14 0.0016
172 EYE PRURITUS 53 0.0016
173 LEFT ATRIAL DILATATION 2 0.0016
174 HEPATIC INFECTION 2 0.0016
175 OCULAR HYPERTENSION 3 0.0015
176 PURULENCE 3 0.0015
177 CARDIOACTIVE DRUG LEVEL INCREASED 2 0.0015
178 NEPHROGENIC ANAEMIA 7 0.0015
179 OSTEOLYSIS 3 0.0015
180 ASTHENOPIA 8 0.0015
181 SWELLING OF EYELID 9 0.0014
182 SENSATION OF FOREIGN BODY 12 0.0014
183 RETINAL DETACHMENT 13 0.0014
184 ESCHERICHIA URINARY TRACT INFECTION 6 0.0014
185 INTENSIVE CARE 2 0.0014
186 EXPOSED BONE IN JAW 3 0.0014
187 VISUAL FIELD DEFECT 10 0.0014
188 ESCHERICHIA SEPSIS 4 0.0014
189 CORNEAL DISORDER 3 0.0014
190 CARDIAC FAILURE ACUTE 9 0.0013
191 AGE-RELATED MACULAR DEGENERATION 2 0.0013
192 TROPONIN INCREASED 10 0.0013
193 EYELIDS PRURITUS 4 0.0013
194 IRIDOCYCLITIS 4 0.0013
195 POLYDIPSIA 5 0.0013
196 INTERMITTENT CLAUDICATION 2 0.0013
197 MYOPIA 3 0.0013
198 INCORRECT DOSE ADMINISTERED BY PRODUCT 2 0.0012
199 EYE OEDEMA 3 0.0012
200 HYPERPARATHYROIDISM SECONDARY 3 0.0012
201 OESOPHAGITIS 13 0.0012
202 PRODUCT DISPENSING ISSUE 5 0.0012
203 EYE MOVEMENT DISORDER 8 0.0012
204 MEDICAL DEVICE REMOVAL 2 0.0012
205 EYE INFLAMMATION 11 0.0012
206 PRODUCT PACKAGING DIFFICULT TO OPEN 3 0.0011
207 PRODUCT CONTAINER SEAL ISSUE 2 0.0011
208 KYPHOSIS 2 0.0011
209 NEOPLASM 13 0.0011
210 MACULOPATHY 4 0.0011
211 URINARY TRACT DISORDER 5 0.0011
212 ERYTHEMA OF EYELID 6 0.0011
213 LIQUID PRODUCT PHYSICAL ISSUE 8 0.0011
214 ESSENTIAL HYPERTENSION 2 0.0011
215 SINUS NODE DYSFUNCTION 2 0.0011
216 TUNNEL VISION 2 0.0011
217 OXYGEN SATURATION ABNORMAL 3 0.0011
218 HYPOREFLEXIA 2 0.0010
219 HAEMOLYSIS 8 0.0010
220 COMA SCALE ABNORMAL 3 0.0010
221 TRAUMATIC LUNG INJURY 2 0.0010
222 HAEMOTHORAX 3 0.0010
223 HYPOVOLAEMIA 6 0.0010
224 NECK INJURY 3 0.0010
225 HYPERAEMIA 2 0.0010
226 CEREBROVASCULAR DISORDER 3 0.0010
227 MUSCULOSKELETAL CHEST PAIN 15 0.0010
228 LOOSE TOOTH 3 0.0009
229 ABNORMAL SENSATION IN EYE 4 0.0009
230 TEARFULNESS 4 0.0009
231 EXOPHTHALMOS 2 0.0009
232 RHINORRHOEA 60 0.0009
233 MYOPATHY 8 0.0009
234 VITREOUS FLOATERS 9 0.0009
235 RENAL FAILURE CHRONIC 7 0.0009
236 ELECTROCARDIOGRAM T WAVE INVERSION 2 0.0009
237 THERAPEUTIC AGENT TOXICITY 3 0.0009
238 MACULAR OEDEMA 5 0.0009
239 DENGUE FEVER 2 0.0009
240 EYE OPERATION 4 0.0009
241 REACTION TO EXCIPIENT 2 0.0009
242 WHEEZING 51 0.0009
243 PRODUCT PACKAGING ISSUE 8 0.0008
244 BREAST CANCER METASTATIC 9 0.0008
245 WRONG DOSE 2 0.0008
246 NASAL CONGESTION 48 0.0008
247 BLINDNESS TRANSIENT 6 0.0008
248 INSTILLATION SITE PAIN 2 0.0008
249 INTRAVENTRICULAR HAEMORRHAGE 2 0.0008
250 OSTEITIS 2 0.0008
251 LABYRINTHITIS 2 0.0008
252 CHEMICAL BURN OF SKIN 2 0.0008
253 PRODUCT CONTAMINATION PHYSICAL 2 0.0008
254 ANGLE CLOSURE GLAUCOMA 2 0.0008
255 PHLEBITIS 4 0.0008
256 ACTINIC KERATOSIS 2 0.0008
257 IRON DEFICIENCY ANAEMIA 7 0.0008
258 NASAL DISORDER 2 0.0008
259 PHOTOPHOBIA 14 0.0007
260 WEIGHT BEARING DIFFICULTY 2 0.0007
261 GAMBLING DISORDER 2 0.0007
262 EYE DISORDER 24 0.0007
263 LARGE INTESTINE POLYP 5 0.0007
264 BLOOD PRESSURE SYSTOLIC INCREASED 14 0.0007
265 NEUTROPENIC SEPSIS 5 0.0007
266 GASTROINTESTINAL NECROSIS 2 0.0007
267 THERAPEUTIC REACTION TIME DECREASED 2 0.0007
268 TOOTH DISCOLOURATION 2 0.0007
269 BLOOD PRESSURE DIASTOLIC DECREASED 5 0.0007
270 RESPIRATORY RATE INCREASED 6 0.0007
271 HEPATITIS FULMINANT 2 0.0007
272 INFUSION SITE REACTION 2 0.0007
273 MASTICATION DISORDER 2 0.0007
274 RECTAL CANCER 2 0.0007
275 ECTOPIC PREGNANCY 2 0.0006
276 PIGMENTATION DISORDER 4 0.0006
277 CONJUNCTIVITIS 12 0.0006
278 ILEUS 8 0.0006
279 GASTRITIS EROSIVE 3 0.0006
280 BASAL CELL CARCINOMA 10 0.0006
281 HYPONATRAEMIA 36 0.0006
282 INFUSION SITE SWELLING 4 0.0006
283 EOSINOPHILIC PNEUMONIA 2 0.0006
284 INFUSION SITE PRURITUS 2 0.0006
285 LACRIMATION INCREASED 19 0.0006
286 FACET JOINT SYNDROME 2 0.0006
287 ESCHERICHIA INFECTION 5 0.0006
288 ORAL CANDIDIASIS 8 0.0006
289 SKIN INJURY 2 0.0006
290 PEPTIC ULCER 2 0.0006
291 APPLICATION SITE SWELLING 3 0.0006
292 PAIN IN JAW 17 0.0006
293 HEART RATE DECREASED 21 0.0006
294 METASTASES TO SPINE 2 0.0006
295 PATHOLOGICAL FRACTURE 3 0.0006
296 DRY EYE 29 0.0006
297 BENIGN PROSTATIC HYPERPLASIA 3 0.0006
298 HAIR GROWTH ABNORMAL 4 0.0006
299 HYPOGLYCAEMIA 28 0.0006
300 HYPOPNOEA 2 0.0006
301 HYPERREFLEXIA 2 0.0006
302 CAROTID ARTERY STENOSIS 2 0.0006
303 TRANSFUSION 6 0.0006
304 HANGOVER 2 0.0006
305 OSTEOARTHRITIS 24 0.0006
306 BONE EROSION 2 0.0006
307 FACIAL PAIN 5 0.0006
308 VIROLOGIC FAILURE 3 0.0006
309 PRODUCT RESIDUE PRESENT 3 0.0006
310 FACIAL BONES FRACTURE 2 0.0006
311 FREQUENT BOWEL MOVEMENTS 15 0.0006
312 SKIN LACERATION 6 0.0006
313 EXTRA DOSE ADMINISTERED 22 0.0005
314 PRODUCT SUBSTITUTION ISSUE 31 0.0005
315 PULMONARY MASS 8 0.0005
316 PRODUCT LEAKAGE 3 0.0005
317 EYE INFECTION 6 0.0005
318 FACE INJURY 2 0.0005
319 HYPERTONIA 3 0.0005
320 CONJUNCTIVAL HAEMORRHAGE 2 0.0005
321 OESOPHAGEAL ULCER 2 0.0005
322 SKIN WARM 3 0.0005
323 SPINAL CORD COMPRESSION 2 0.0005
324 FEELING OF BODY TEMPERATURE CHANGE 3 0.0005
325 VISUAL ACUITY REDUCED 17 0.0005
326 EYE SWELLING 19 0.0005
327 VISION BLURRED 70 0.0005
328 PNEUMONIA FUNGAL 2 0.0005
329 SINUS HEADACHE 3 0.0005
330 TRICUSPID VALVE INCOMPETENCE 4 0.0005
331 PRODUCTIVE COUGH 24 0.0005
332 MACULAR DEGENERATION 6 0.0005
333 CORONARY ARTERY DISEASE 15 0.0005
334 EYELID PTOSIS 5 0.0005
335 PERIPHERAL ARTERIAL OCCLUSIVE DISEASE 2 0.0005
336 POLYURIA 4 0.0005
337 GLOMERULAR FILTRATION RATE DECREASED 6 0.0005
338 CATARACT 29 0.0005
339 CONCOMITANT DISEASE AGGRAVATED 3 0.0005
340 HYPERSENSITIVITY 90 0.0005
341 HYPERKALAEMIA 17 0.0005
342 ACUTE KIDNEY INJURY 74 0.0005
343 SOCIAL PROBLEM 2 0.0005
344 INFUSION SITE EXTRAVASATION 3 0.0005
345 GASTROENTERITIS 7 0.0005
346 BRADYCARDIA 25 0.0005
347 ONYCHOMYCOSIS 2 0.0005
348 SPINAL OSTEOARTHRITIS 4 0.0005
349 WALKING AID USER 3 0.0005
350 PRODUCT FORMULATION ISSUE 3 0.0005
351 GINGIVAL SWELLING 2 0.0005
352 LUNG INFILTRATION 4 0.0005
353 ASTHMA 51 0.0005
354 FOOT DEFORMITY 5 0.0005
355 EAR INFECTION 12 0.0005
356 HAEMOLYTIC ANAEMIA 4 0.0004
357 MYOSITIS 4 0.0004
358 PRODUCT LABEL ISSUE 3 0.0004
359 URINE ABNORMALITY 2 0.0004
360 HYPERGLYCAEMIA 16 0.0004
361 RIB FRACTURE 9 0.0004
362 LUMBAR VERTEBRAL FRACTURE 2 0.0004
363 LARGE INTESTINE PERFORATION 3 0.0004
364 MADAROSIS 5 0.0004
365 EYELID OEDEMA 5 0.0004
366 EXTRASYSTOLES 3 0.0004
367 EPISTAXIS 32 0.0004
368 BLINDNESS UNILATERAL 6 0.0004
369 SPINAL COLUMN STENOSIS 2 0.0004
370 DIVERTICULUM 3 0.0004
371 CHRONIC LYMPHOCYTIC LEUKAEMIA 2 0.0004
372 HYPERLIPIDAEMIA 5 0.0004
373 GASTRITIS 11 0.0004
374 FAECAL INCONTINENCE 2 0.0004
375 DIZZINESS POSTURAL 4 0.0004
376 VISUAL IMPAIRMENT 51 0.0004
377 ORAL DISORDER 3 0.0004
378 CEREBRAL DISORDER 3 0.0004
379 HEPATIC ENZYME ABNORMAL 2 0.0004
380 HAEMATEMESIS 10 0.0004
381 TOOTH ABSCESS 4 0.0004
382 ABDOMINAL INFECTION 1 0.0004
383 FEMORAL NECK FRACTURE 2 0.0004
384 ABNORMAL UTERINE BLEEDING 1 0.0004
385 PERIPHERAL VASCULAR DISORDER 2 0.0004
386 VARICOSE VEIN 2 0.0004
387 INTERNATIONAL NORMALISED RATIO INCREASED 11 0.0004
388 MYASTHENIA GRAVIS 3 0.0004
389 HIP SURGERY 2 0.0004
390 FAECES DISCOLOURED 8 0.0004
391 ABDOMINAL RIGIDITY 1 0.0004
392 BLINDNESS 15 0.0004
393 SLEEP APNOEA SYNDROME 7 0.0004
394 MANIA 6 0.0004
395 NONSPECIFIC REACTION 2 0.0004
396 MUSCULOSKELETAL PAIN 19 0.0004
397 HYPERKERATOSIS 2 0.0004
398 RHABDOMYOLYSIS 15 0.0004
399 HAEMODIALYSIS 3 0.0004
400 PRODUCT DOSE OMISSION ISSUE 105 0.0004
401 PERIORBITAL SWELLING 2 0.0004
402 RENAL FAILURE ACUTE 15 0.0004
403 MITRAL VALVE INCOMPETENCE 4 0.0004
404 SEASONAL ALLERGY 5 0.0004
405 COUGH 99 0.0004
406 CHOLECYSTITIS ACUTE 2 0.0004
407 DEHYDRATION 47 0.0004
408 HAEMOGLOBIN DECREASED 36 0.0004
409 SKIN ULCER 9 0.0003
410 DELIRIUM 12 0.0003
411 HALLUCINATION 26 0.0003
412 ENERGY INCREASED 2 0.0003
413 CARDIAC PACEMAKER INSERTION 2 0.0003
414 ACCIDENT 4 0.0003
415 PROTHROMBIN TIME PROLONGED 2 0.0003
416 ENDOPHTHALMITIS 2 0.0003
417 OROPHARYNGEAL DISCOMFORT 3 0.0003
418 ECONOMIC PROBLEM 5 0.0003
419 END STAGE RENAL DISEASE 6 0.0003
420 MENTAL STATUS CHANGES 9 0.0003
421 PRURITUS GENERALISED 7 0.0003
422 SCOLIOSIS 2 0.0003
423 DELUSION 5 0.0003
424 HAEMATURIA 11 0.0003
425 PSORIATIC ARTHROPATHY 13 0.0003
426 HEPATIC CIRRHOSIS 6 0.0003
427 NEUTROPHIL COUNT DECREASED 13 0.0003
428 ARTERIOSCLEROSIS 3 0.0003
429 MULTIPLE INJURIES 2 0.0003
430 PHOTOPSIA 2 0.0003
431 PNEUMOTHORAX 5 0.0003
432 SUPRAVENTRICULAR TACHYCARDIA 3 0.0003
433 ORAL PAIN 7 0.0003
434 SNEEZING 7 0.0003
435 DISCOMFORT 19 0.0003
436 ATELECTASIS 3 0.0003
437 PARKINSONISM 3 0.0003
438 VITAMIN D DEFICIENCY 3 0.0003
439 HEPATOMEGALY 3 0.0003
440 BODY TEMPERATURE DECREASED 3 0.0003
441 ASPERGILLUS INFECTION 2 0.0003
442 PULMONARY CONGESTION 4 0.0003
443 LIGAMENT SPRAIN 3 0.0003
444 HAEMATOCRIT DECREASED 6 0.0003
445 CYTOKINE RELEASE SYNDROME 6 0.0003
446 TERMINAL STATE 2 0.0003
447 ATRIOVENTRICULAR BLOCK COMPLETE 2 0.0003
448 CHOLECYSTITIS CHRONIC 2 0.0003
449 CONFUSIONAL STATE 48 0.0003
450 INTENTIONAL PRODUCT USE ISSUE 26 0.0003
451 WRONG PRODUCT ADMINISTERED 2 0.0003
452 PRODUCT TASTE ABNORMAL 4 0.0003
453 SUBARACHNOID HAEMORRHAGE 3 0.0003
454 BLOOD PRESSURE INCREASED 45 0.0003
455 PALLOR 8 0.0003
456 ECCHYMOSIS 2 0.0003
457 BONE PAIN 17 0.0003
458 HYPERBILIRUBINAEMIA 3 0.0003
459 DROOLING 2 0.0003
460 TENDERNESS 3 0.0003
461 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 15 0.0003
462 ORTHOSTATIC HYPOTENSION 5 0.0003
463 DEFAECATION URGENCY 2 0.0003
464 INCONTINENCE 3 0.0003
465 EATING DISORDER 6 0.0003
466 METASTASIS 2 0.0003
467 DRUG INTERACTION 44 0.0003
468 ATRIAL FIBRILLATION 27 0.0003
469 FAECES SOFT 2 0.0003
470 CLOSTRIDIUM DIFFICILE INFECTION 6 0.0003
471 MUSCULOSKELETAL STIFFNESS 24 0.0003
472 HYPOPHAGIA 7 0.0003
473 LOSS OF CONSCIOUSNESS 35 0.0003
474 FEBRILE NEUTROPENIA 18 0.0003
475 BURNING SENSATION 19 0.0003
476 HYPOPHOSPHATAEMIA 2 0.0003
477 LOWER GASTROINTESTINAL HAEMORRHAGE 2 0.0003
478 LIP SWELLING 9 0.0003
479 DRUG INTOLERANCE 26 0.0003
480 DEAFNESS 7 0.0003
481 THERAPY NON-RESPONDER 12 0.0003
482 BLOOD SODIUM DECREASED 5 0.0003
483 FRACTURE 5 0.0003
484 ASPARTATE AMINOTRANSFERASE INCREASED 14 0.0003
485 PRODUCT AVAILABILITY ISSUE 6 0.0003
486 AORTIC ANEURYSM 2 0.0003
487 SWELLING FACE 17 0.0003
488 ACUTE RESPIRATORY FAILURE 5 0.0003
489 PERIPHERAL SWELLING 40 0.0003
490 THYROID DISORDER 4 0.0003
491 FOOD ALLERGY 2 0.0003
492 ATRIOVENTRICULAR BLOCK 2 0.0003
493 LIMB INJURY 7 0.0003
494 PELVIC FRACTURE 2 0.0003
495 ACUTE MYELOID LEUKAEMIA 4 0.0003
496 HYPOACUSIS 11 0.0003
497 ELECTROCARDIOGRAM ABNORMAL 2 0.0003
498 PRODUCT ADMINISTRATION INTERRUPTED 2 0.0003
499 ARTHRITIS 20 0.0003
500 COVID-19 PNEUMONIA 3 0.0003
501 PRODUCT USE COMPLAINT 4 0.0003
502 ATAXIA 3 0.0003
503 BACTERAEMIA 3 0.0003
504 FURUNCLE 2 0.0003
505 NASAL DISCOMFORT 2 0.0003
506 BLOOD ALBUMIN DECREASED 2 0.0003
507 SENSORY DISTURBANCE 4 0.0002
508 RHINITIS 2 0.0002
509 FRUSTRATION TOLERANCE DECREASED 2 0.0002
510 PRODUCT ADMINISTRATION ERROR 5 0.0002
511 FEEDING DISORDER 5 0.0002
512 ANAEMIA 47 0.0002
513 POST PROCEDURAL INFECTION 2 0.0002
514 GASTROINTESTINAL DISORDER 22 0.0002
515 DECUBITUS ULCER 2 0.0002
516 HICCUPS 2 0.0002
517 BLOOD CREATINE PHOSPHOKINASE INCREASED 7 0.0002
518 UPPER-AIRWAY COUGH SYNDROME 2 0.0002
519 PHOTOSENSITIVITY REACTION 4 0.0002
520 SPINAL COMPRESSION FRACTURE 2 0.0002
521 ACUTE CORONARY SYNDROME 2 0.0002
522 SECOND PRIMARY MALIGNANCY 2 0.0002
523 DYSPNOEA EXERTIONAL 9 0.0002
524 BLOOD UREA INCREASED 4 0.0002
525 UPPER GASTROINTESTINAL HAEMORRHAGE 4 0.0002
526 INFUSION SITE ERYTHEMA 2 0.0002
527 FACE OEDEMA 4 0.0002
528 HALLUCINATION, VISUAL 5 0.0002
529 HEMIPARESIS 4 0.0002
530 RENAL INJURY 7 0.0002
531 INJECTION SITE SWELLING 18 0.0002
532 INFUSION SITE PAIN 3 0.0002
533 BLOOD MAGNESIUM DECREASED 2 0.0002
534 PRODUCT PRESCRIBING ISSUE 5 0.0002
535 GROIN PAIN 2 0.0002
536 TUMOUR LYSIS SYNDROME 2 0.0002
537 MELAENA 5 0.0002
538 COLD SWEAT 4 0.0002
539 ABDOMINAL ABSCESS 1 0.0002
540 HEAD DISCOMFORT 4 0.0002
541 CONSTIPATION 49 0.0002
542 JOINT RANGE OF MOTION DECREASED 3 0.0002
543 DYSPEPSIA 22 0.0002
544 FEAR 6 0.0002
545 URINARY TRACT INFECTION 38 0.0002
546 ANAL INCONTINENCE 2 0.0002
547 DYSPHONIA 13 0.0002
548 SINUS CONGESTION 3 0.0002
549 HEART RATE IRREGULAR 5 0.0002
550 DYSPHAGIA 21 0.0002
551 HEAD INJURY 7 0.0002
552 IMPAIRED GASTRIC EMPTYING 3 0.0002
553 MOVEMENT DISORDER 7 0.0002
554 PNEUMONIA BACTERIAL 2 0.0002
555 BRAIN NEOPLASM 2 0.0002
556 TINNITUS 10 0.0002
557 SHOCK 5 0.0002
558 RESPIRATORY DISTRESS 6 0.0002
559 UROSEPSIS 2 0.0002
560 PERICARDIAL EFFUSION 5 0.0002
561 POLLAKIURIA 9 0.0002
562 FEELING COLD 6 0.0002
563 HUNGER 3 0.0002
564 COORDINATION ABNORMAL 3 0.0002
565 DEFORMITY 2 0.0002
566 SQUAMOUS CELL CARCINOMA 2 0.0002
567 CARDIAC FAILURE 17 0.0002
568 ALANINE AMINOTRANSFERASE INCREASED 13 0.0002
569 SINUS TACHYCARDIA 3 0.0002
570 BLOOD URINE PRESENT 4 0.0002
571 EXPIRED PRODUCT ADMINISTERED 7 0.0002
572 DIZZINESS 105 0.0002
573 FALL 70 0.0002
574 SUBDURAL HAEMATOMA 3 0.0002
575 CARDIOGENIC SHOCK 3 0.0002
576 LETHARGY 12 0.0002
577 DIABETIC KETOACIDOSIS 5 0.0002
578 JOINT SWELLING 25 0.0002
579 SINUS BRADYCARDIA 2 0.0002
580 PRESYNCOPE 5 0.0002
581 CHOKING 4 0.0002
582 RENAL TUBULAR NECROSIS 2 0.0002
583 DECREASED IMMUNE RESPONSIVENESS 2 0.0002
584 THERAPY CHANGE 2 0.0002
585 RASH PRURITIC 11 0.0002
586 DISABILITY 4 0.0002
587 EMPHYSEMA 2 0.0002
588 BACK PAIN 46 0.0002
589 OSTEOPENIA 3 0.0002
590 TASTE DISORDER 4 0.0002
591 INSURANCE ISSUE 3 0.0002
592 SLUGGISHNESS 2 0.0002
593 ANKLE FRACTURE 3 0.0002
594 HAEMATOMA 5 0.0002
595 VENTRICULAR EXTRASYSTOLES 2 0.0002
596 THERAPY PARTIAL RESPONDER 3 0.0002
597 WEIGHT FLUCTUATION 2 0.0002
598 PRODUCT ODOUR ABNORMAL 2 0.0002
599 DYSPNOEA 108 0.0002
600 PAIN IN EXTREMITY 56 0.0002
601 SCRATCH 2 0.0002
602 NEUROPATHY PERIPHERAL 18 0.0002
603 RESPIRATORY TRACT CONGESTION 3 0.0002
604 OBESITY 3 0.0002
605 SCIATICA 3 0.0002
606 JAUNDICE 5 0.0002
607 DECREASED ACTIVITY 2 0.0002
608 LACTIC ACIDOSIS 6 0.0002
609 ARTHRALGIA 77 0.0002
610 BLOOD POTASSIUM INCREASED 3 0.0002
611 COLITIS 7 0.0002
612 HYPOTENSION 37 0.0002
613 BACK INJURY 2 0.0002
614 DIABETES MELLITUS 14 0.0002
615 WOUND INFECTION 2 0.0002
616 BLOOD GLUCOSE FLUCTUATION 2 0.0002
617 TOOTH FRACTURE 2 0.0002
618 DRUG LEVEL INCREASED 3 0.0002
619 BLOOD PRESSURE DECREASED 12 0.0002
620 LEUKOPENIA 9 0.0002
621 NERVE INJURY 2 0.0002
622 OXYGEN SATURATION DECREASED 10 0.0002
623 FISTULA 2 0.0002
624 TRANSIENT ISCHAEMIC ATTACK 6 0.0002
625 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 6 0.0002
626 CHROMATURIA 4 0.0002
627 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 3 0.0002
628 NO ADVERSE EVENT 32 0.0002
629 PRODUCT DOSE OMISSION IN ERROR 5 0.0002
630 CIRCULATORY COLLAPSE 3 0.0002
631 ASTHENIA 66 0.0002
632 INTENTIONAL DOSE OMISSION 5 0.0002
633 DERMATITIS CONTACT 2 0.0002
634 SCAB 2 0.0002
635 MICTURITION URGENCY 2 0.0002
636 INTERNAL HAEMORRHAGE 2 0.0002
637 NEPHROLITHIASIS 8 0.0002
638 CARDIAC FAILURE CONGESTIVE 14 0.0002
639 HERPES ZOSTER 10 0.0002
640 GASTRIC HAEMORRHAGE 2 0.0002
641 HOT FLUSH 13 0.0002
642 POST PROCEDURAL HAEMORRHAGE 2 0.0002
643 VASCULITIS 2 0.0002
644 RASH MACULAR 6 0.0002
645 DYSSTASIA 5 0.0002
646 NEUROTOXICITY 3 0.0002
647 INCORRECT DOSE ADMINISTERED 39 0.0002
648 OSTEOPOROSIS 7 0.0002
649 SYNCOPE 17 0.0002
650 ACUTE MYOCARDIAL INFARCTION 5 0.0002
651 INSOMNIA 45 0.0002
652 TACHYCARDIA 15 0.0002
653 BLOOD CREATININE INCREASED 11 0.0002
654 GALLBLADDER DISORDER 3 0.0002
655 RASH ERYTHEMATOUS 8 0.0002
656 TOOTHACHE 3 0.0002
657 OSTEOMYELITIS 3 0.0002
658 RESTLESS LEGS SYNDROME 3 0.0002
659 ADRENAL INSUFFICIENCY 2 0.0002
660 CYTOPENIA 2 0.0002
661 INJECTION SITE BRUISING 13 0.0002
662 RECTAL HAEMORRHAGE 7 0.0002
663 SMALL INTESTINAL OBSTRUCTION 2 0.0002
664 PANCYTOPENIA 9 0.0002
665 BACTERIAL INFECTION 3 0.0002
666 PNEUMONIA ASPIRATION 4 0.0002
667 SECRETION DISCHARGE 2 0.0002
668 CELLULITIS 8 0.0002
669 FOOT FRACTURE 3 0.0002
670 GASTRIC ULCER 3 0.0002
671 WEIGHT DECREASED 44 0.0002
672 MUSCULOSKELETAL DISORDER 3 0.0002
673 PNEUMONIA 51 0.0002
674 FLUID RETENTION 8 0.0002
675 PULMONARY FIBROSIS 3 0.0002
676 METABOLIC ACIDOSIS 5 0.0002
677 HEADACHE 98 0.0002
678 PYREXIA 54 0.0002
679 ROTATOR CUFF SYNDROME 2 0.0002
680 ANOREXIA 2 0.0002
681 NIGHT SWEATS 5 0.0002
682 ABDOMINAL DISCOMFORT 26 0.0002
683 RENAL IMPAIRMENT 13 0.0002
684 HIATUS HERNIA 2 0.0002
685 EXPOSURE VIA SKIN CONTACT 4 0.0002
686 RESPIRATORY TRACT INFECTION 4 0.0002
687 CHILLS 18 0.0002
688 PLATELET COUNT INCREASED 2 0.0002
689 MYALGIA 26 0.0002
690 CHOLELITHIASIS 5 0.0002
691 IMMUNE SYSTEM DISORDER 2 0.0002
692 TOOTH INFECTION 2 0.0002
693 GAIT DISTURBANCE 29 0.0002
694 SINUS DISORDER 3 0.0002
695 MALAISE 66 0.0002
696 BALANCE DISORDER 13 0.0002
697 INJECTION SITE HAEMORRHAGE 12 0.0002
698 PLATELET COUNT DECREASED 16 0.0001
699 SKIN DISORDER 5 0.0001
700 URINARY RETENTION 5 0.0001
701 HAIR TEXTURE ABNORMAL 2 0.0001
702 MALIGNANT MELANOMA 2 0.0001
703 DIARRHOEA 95 0.0001
704 CHEST PAIN 27 0.0001
705 ILLNESS 15 0.0001
706 CHRONIC KIDNEY DISEASE 11 0.0001
707 ARTHROPATHY 8 0.0001
708 FATIGUE 112 0.0001
709 HYPOMAGNESAEMIA 2 0.0001
710 SEPSIS 16 0.0001
711 DRUG INEFFECTIVE 189 0.0001
712 DERMATITIS 3 0.0001
713 WOUND 4 0.0001
714 MASS 2 0.0001
715 MOUTH ULCERATION 3 0.0001
716 DECREASED APPETITE 33 0.0001
717 DIALYSIS 2 0.0001
718 JOINT INJURY 3 0.0001
719 HYPERSOMNIA 4 0.0001
720 OEDEMA PERIPHERAL 17 0.0001
721 POOR QUALITY SLEEP 3 0.0001
722 SKIN CANCER 3 0.0001
723 INTERVERTEBRAL DISC PROTRUSION 3 0.0001
724 APATHY 2 0.0001
725 ERYTHEMA 28 0.0001
726 DRY MOUTH 11 0.0001
727 RENAL FAILURE 18 0.0001
728 CARDIOMYOPATHY 2 0.0001
729 LIVER DISORDER 6 0.0001
730 URINARY INCONTINENCE 4 0.0001
731 DRUG EFFECT LESS THAN EXPECTED 2 0.0001
732 TOOTH DISORDER 3 0.0001
733 RASH MACULO-PAPULAR 3 0.0001
734 COLON CANCER 2 0.0001
735 THROMBOCYTOPENIA 15 0.0001
736 SOMNOLENCE 27 0.0001
737 THERAPEUTIC PRODUCT EFFECT DECREASED 6 0.0001
738 HAEMORRHAGE INTRACRANIAL 2 0.0001
739 FEELING ABNORMAL 32 0.0001
740 BONE LOSS 2 0.0001
741 BLOOD POTASSIUM DECREASED 4 0.0001
742 HYPOAESTHESIA ORAL 2 0.0001
743 HYPERTENSION 28 0.0001
744 MUSCULAR WEAKNESS 15 0.0001
745 LOWER RESPIRATORY TRACT INFECTION 6 0.0001
746 BLOOD COUNT ABNORMAL 2 0.0001
747 GASTROINTESTINAL HAEMORRHAGE 11 0.0001
748 DEVICE FAILURE 2 0.0001
749 SKIN DISCOLOURATION 6 0.0001
750 SKIN EXFOLIATION 11 0.0001
751 NASOPHARYNGITIS 24 0.0001
752 DEVICE RELATED INFECTION 2 0.0001
753 WEIGHT INCREASED 29 0.0001
754 TENDONITIS 2 0.0001
755 ABDOMINAL PAIN 30 0.0001
756 EJECTION FRACTION DECREASED 2 0.0001
757 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 6 0.0001
758 SWOLLEN TONGUE 4 0.0001
759 ARRHYTHMIA 6 0.0001
760 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 9 0.0001
761 DEPRESSED LEVEL OF CONSCIOUSNESS 5 0.0001
762 OFF LABEL USE 110 0.0001
763 VOMITING 59 0.0001
764 MUSCLE SPASMS 23 0.0001
765 NEUTROPENIA 17 0.0001
766 BLOOD PRESSURE FLUCTUATION 3 0.0001
767 LOCALISED INFECTION 3 0.0001
768 MUSCLE TIGHTNESS 2 0.0001
769 FLATULENCE 7 0.0001
770 UNDERDOSE 9 0.0001
771 BACK DISORDER 2 0.0001
772 ADVERSE DRUG REACTION 11 0.0001
773 METASTASES TO BONE 2 0.0001
774 BRONCHITIS 9 0.0001
775 OSTEONECROSIS OF JAW 3 0.0001
776 DYSGEUSIA 9 0.0001
777 HEART RATE INCREASED 12 0.0001
778 VENTRICULAR TACHYCARDIA 2 0.0001
779 COAGULOPATHY 2 0.0001
780 COVID-19 21 0.0001
781 PERICARDITIS 2 0.0001
782 UNEVALUABLE EVENT 9 0.0001
783 GLYCOSYLATED HAEMOGLOBIN INCREASED 3 0.0001
784 SCAR 2 0.0001
785 MUSCULOSKELETAL DISCOMFORT 2 0.0001
786 PARANOIA 2 0.0001
787 MULTI-ORGAN FAILURE 2 0.0001
788 NIGHTMARE 4 0.0001
789 ILL-DEFINED DISORDER 7 0.0001
790 ABDOMINAL DISTENSION 12 0.0001
791 PSORIASIS 15 0.0001
792 PRURITUS 44 0.0001
793 ANHEDONIA 3 0.0001
794 DEPRESSED MOOD 6 0.0001
795 DIABETES MELLITUS INADEQUATE CONTROL 2 0.0001
796 CEREBROVASCULAR ACCIDENT 19 0.0001
797 ISCHAEMIC STROKE 2 0.0001
798 THIRST 2 0.0001
799 THROAT IRRITATION 5 0.0001
800 THROAT TIGHTNESS 3 0.0001
801 RESPIRATORY FAILURE 8 0.0001
802 TREATMENT NONCOMPLIANCE 6 0.0001
803 SKIN LESION 3 0.0001
804 ACCIDENTAL OVERDOSE 4 0.0001
805 SKIN IRRITATION 5 0.0001
806 AGITATION 8 0.0001
807 RESPIRATORY ARREST 3 0.0001
808 HAEMATOCHEZIA 6 0.0001
809 DYSURIA 4 0.0001
810 CHEST DISCOMFORT 11 0.0001
811 DEMENTIA 3 0.0001
812 MIDDLE INSOMNIA 2 0.0001
813 COGNITIVE DISORDER 5 0.0001
814 TUBULOINTERSTITIAL NEPHRITIS 2 0.0001
815 HYPOCALCAEMIA 2 0.0001
816 RED BLOOD CELL COUNT DECREASED 3 0.0001
817 SEROTONIN SYNDROME 2 0.0001
818 PANCREATIC CARCINOMA 3 0.0001
819 HAEMORRHOIDS 2 0.0001
820 PLASMA CELL MYELOMA 4 0.0001
821 TREMOR 17 0.0001
822 ANXIETY 29 0.0001
823 MEMORY IMPAIRMENT 14 0.0001
824 LABORATORY TEST ABNORMAL 3 0.0001
825 PRODUCT USE ISSUE 19 0.0001
826 BLOOD PRESSURE ABNORMAL 2 0.0001
827 UPPER LIMB FRACTURE 2 0.0001
828 RESPIRATORY DISORDER 3 0.0001
829 SPINAL FRACTURE 2 0.0001
830 FULL BLOOD COUNT DECREASED 2 0.0001
831 PRODUCT PHYSICAL ISSUE 2 0.0001
832 THERAPEUTIC RESPONSE DECREASED 6 0.0001
833 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 20 0.0001
834 CONDITION AGGRAVATED 30 0.0001
835 THERAPY INTERRUPTED 7 0.0001
836 FEELING HOT 6 0.0001
837 THERAPY CESSATION 5 0.0001
838 INFLAMMATION 5 0.0001
839 PULMONARY HYPERTENSION 2 0.0001
840 PRODUCT QUALITY ISSUE 13 0.0001
841 CARDIO-RESPIRATORY ARREST 4 0.0001
842 INJECTION SITE PAIN 29 0.0001
843 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 17 0.0001
844 PALPITATIONS 11 0.0001
845 HYPERHIDROSIS 12 0.0001
846 DEPRESSION 21 0.0001
847 NAUSEA 73 0.0001
848 AMNESIA 6 0.0001
849 VAGINAL HAEMORRHAGE 4 0.0001
850 DEVICE DISLOCATION 4 0.0001
851 SEPTIC SHOCK 4 0.0001
852 IMPAIRED HEALING 3 0.0001
853 PAIN 56 0.0001
854 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 5 0.0001
855 STAPHYLOCOCCAL INFECTION 3 0.0001
856 DEVICE DIFFICULT TO USE 6 0.0001
857 VIRAL INFECTION 3 0.0001
858 MEDICATION ERROR 5 0.0001
859 TRANSAMINASES INCREASED 2 0.0001
860 NECK PAIN 5 0.0001
861 PULMONARY OEDEMA 4 0.0001
862 PANCREATITIS ACUTE 2 0.0001
863 GASTRIC DISORDER 3 0.0001
864 HYPOAESTHESIA 13 0.0001
865 HYPOKALAEMIA 4 0.0001
866 HAEMORRHAGE 9 0.0001
867 RENAL DISORDER 4 0.0001
868 HYPOXIA 3 0.0001
869 INFLUENZA LIKE ILLNESS 7 0.0001
870 DISEASE PROGRESSION 10 0.0001
871 DISEASE RECURRENCE 4 0.0001
872 CEREBRAL HAEMORRHAGE 3 0.0001
873 BLOOD GLUCOSE DECREASED 4 0.0001
874 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 4 0.0001
875 IRRITABILITY 5 0.0001
876 CONTUSION 8 0.0001
877 WHITE BLOOD CELL COUNT DECREASED 9 0.0001
878 INTERSTITIAL LUNG DISEASE 4 0.0001
879 ABDOMINAL PAIN UPPER 17 0.0001
880 MENTAL IMPAIRMENT 2 0.0001
881 PANIC ATTACK 3 0.0001
882 NEURALGIA 2 0.0001
883 PLEURAL EFFUSION 5 0.0001
884 LIVER INJURY 2 0.0001
885 INFLUENZA 9 0.0001
886 HEPATIC FUNCTION ABNORMAL 3 0.0001
887 AGEUSIA 2 0.0001
888 ACNE 6 0.0001
889 WHITE BLOOD CELL COUNT INCREASED 3 0.0001
890 HOSPITALISATION 12 0.0001
891 ERECTILE DYSFUNCTION 2 0.0001
892 GENERAL PHYSICAL HEALTH DETERIORATION 9 0.0001
893 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 2 0.0001
894 ACCIDENTAL EXPOSURE TO PRODUCT 8 0.0001
895 DIPLOPIA 2 0.0001
896 DEEP VEIN THROMBOSIS 5 0.0001
897 PRODUCT USE IN UNAPPROVED INDICATION 19 0.0001
898 ECZEMA 4 0.0001
899 MUCOSAL INFLAMMATION 2 0.0001
900 SPEECH DISORDER 4 0.0001
901 INCORRECT DOSE ADMINISTERED BY DEVICE 2 0.0001
902 PARAESTHESIA 12 0.0001
903 JOINT STIFFNESS 2 0.0001
904 PANCREATITIS 4 0.0001
905 DRY SKIN 10 0.0001
906 CARDIAC DISORDER 7 0.0001
907 SWELLING 7 0.0001
908 THROMBOSIS 6 0.0001
909 MYOCARDIAL INFARCTION 13 0.0001
910 HEPATIC ENZYME INCREASED 5 0.0001
911 MOOD ALTERED 2 0.0001
912 DEVICE DELIVERY SYSTEM ISSUE 2 0.0001
913 CARDIAC ARREST 6 0.0001
914 ANAPHYLACTIC REACTION 4 0.0001
915 PROCEDURAL PAIN 2 0.0001
916 BLISTER 4 0.0001
917 INJURY 5 0.0001
918 MOBILITY DECREASED 5 0.0001
919 MENTAL DISORDER 3 0.0001
920 RASH 30 0.0001
921 LIVER FUNCTION TEST ABNORMAL 2 0.0001
922 APHASIA 2 0.0001
923 TOXICITY TO VARIOUS AGENTS 11 0.0001
924 EMOTIONAL DISORDER 2 0.0001
925 GYNAECOMASTIA 2 0.0001
926 LIMB DISCOMFORT 2 0.0001
927 FEMUR FRACTURE 2 0.0001
928 BLOOD CHOLESTEROL INCREASED 3 0.0001
929 DRUG-INDUCED LIVER INJURY 2 0.0001
930 BLOOD GLUCOSE INCREASED 12 0.0001
931 MOOD SWINGS 2 0.0001
932 ABSCESS 1 0.0001
933 INFECTION 9 0.0001
934 LUNG DISORDER 3 0.0001
935 ALOPECIA 12 0.0001
936 OSTEONECROSIS 2 0.0001
937 DEATH 52 0.0001
938 THERAPEUTIC RESPONSE SHORTENED 2 0.0001
939 FUNGAL INFECTION 2 0.0001
940 GAIT INABILITY 2 0.0001
941 ANGER 2 0.0001
942 SINUSITIS 6 0.0001
943 INJECTION SITE ERYTHEMA 7 0.0001
944 DISTURBANCE IN ATTENTION 3 0.0001
945 OEDEMA 3 0.0001
946 C-REACTIVE PROTEIN INCREASED 2 0.0001
947 SUICIDAL IDEATION 5 0.0001
948 PULMONARY EMBOLISM 5 0.0001
949 CONVULSION 3 0.0001
950 ABNORMAL BEHAVIOUR 2 0.0001
951 DISORIENTATION 2 0.0001
952 GASTROOESOPHAGEAL REFLUX DISEASE 4 0.0000
953 VERTIGO 3 0.0000
954 MALIGNANT NEOPLASM PROGRESSION 5 0.0000
955 LUNG NEOPLASM MALIGNANT 2 0.0000
956 URTICARIA 8 0.0000
957 OVERDOSE 10 0.0000
958 ANGIOEDEMA 2 0.0000
959 COLITIS ULCERATIVE 2 0.0000
960 THERAPEUTIC RESPONSE UNEXPECTED 2 0.0000
961 RHEUMATOID ARTHRITIS 5 0.0000
962 UPPER RESPIRATORY TRACT INFECTION 2 0.0000
963 DEVICE MALFUNCTION 3 0.0000
964 SLEEP DISORDER 3 0.0000
965 COMA 2 0.0000
966 ABASIA 1 0.0000
967 AGGRESSION 2 0.0000
968 ABDOMINAL PAIN LOWER 1 0.0000
969 FLUSHING 4 0.0000
970 NERVOUSNESS 2 0.0000
971 PROSTATE CANCER 3 0.0000
972 DRUG EFFECT DECREASED 2 0.0000
973 ABNORMAL DREAMS 1 0.0000
974 SEIZURE 4 0.0000
975 PRODUCT STORAGE ERROR 3 0.0000
976 BLADDER CANCER 2 0.0000
977 DEVICE ISSUE 3 0.0000
978 EMOTIONAL DISTRESS 4 0.0000
979 ADVERSE EVENT 3 0.0000
980 OROPHARYNGEAL PAIN 3 0.0000
981 INTENTIONAL OVERDOSE 2 0.0000
982 PRODUCT DOSE OMISSION 2 0.0000
983 INFUSION RELATED REACTION 2 0.0000
984 NEOPLASM MALIGNANT 2 0.0000
985 MULTIPLE SCLEROSIS RELAPSE 2 0.0000
986 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 2 0.0000
987 SKIN BURNING SENSATION 2 0.0000
988 ABORTION SPONTANEOUS 1 0.0000
989 FOETAL EXPOSURE DURING PREGNANCY 2 0.0000
990 DRUG DOSE OMISSION 4 0.0000
991 INTENTIONAL PRODUCT MISUSE 2 0.0000